Selleck Chemicals - Model A2365 -Rosmantuzumab (anti-RSPO3)

Rosmantuzumab (OMP-131R10) is an immunoglobulin (Ig) G1 humanized monoclonal antibody targeting human R-spondin 3 (RSPO3) with potential immunostimulating and antineoplastic activities. MW: 145.5 kD.